Clinical effectiveness and cost-effectiveness of using positive airways pressure to manage sleep apnoea in patients with type 2 diabetes in the UK

Sep-13

AUTHORS : Dr Julian F Guest, CATALYST, PO Box 9429, Poole BH4 0HA – Email: julian.guest@catalyst-health.com – Profile: https://catalyst-health.co.uk/about-us/

JOURNAL : Diabetologia

REFERENCE: 56(S1):S41

DOI : 10.1007/s00125-013-3012-z

Clinical effectiveness and cost-effectiveness of using positive airways pressure to manage sleep apnoea in patients with type 2 diabetes in the UK

More publications

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US

Duration of Invasive Mechanical Ventilation before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 related Acute Respiratory Distress Syndrome: The experience of a tertiary care center

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis